Posaconazole | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Posaconazole
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Posaconazole

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

57 API Suppliers, 27 USDMF, 10 EU WC, 2 KDMF, 18 NDC API, 38 Listed Suppliers, $ API Reference Price

57 API Suppliers
27 USDMF
10 EU WC
2 KDMF
18 NDC API
38 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

INTERMEDIATES

58 Intermediate Suppliers

58 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

98 FDF Dossiers, 23 FDA Orange Book, 40 Europe, 8 Canada, 6 Australia, 1 South Africa, 20 Listed Dossiers

98 FDF Dossiers
23 FDA Orange Book
40 Europe
8 Canada
6 Australia
1 South Africa
20 Listed Dossiers

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 1 SPI Pharma, 5 DKSH, 1 Pharm-RX Chemical, 2 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 7 Actylis, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 BASF, 5 Corel Pharma Chem, 3 DFE Pharma, 11 Gangwal Chemicals, 3 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 7 Kerry, 1 Lonza Capsugel, 7 Microlex e.U, 1 Nanjing Bold Chemical, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 10 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

22 Coating Systems & Additives, 21 Fillers, Diluents & Binders, 16 Thickeners and Stabilizers, 14 Disintegrants & Superdisintegrants, 13 Parenteral, 13 Lubricants & Glidants, 12 Solubilizers, 12 Controlled & Modified Release, 10 Direct Compression, 9 Topical, 8 Film Formers & Plasticizers, 7 Granulation, 7 Emulsifying Agents, 6 Co-Processed Excipients, 5 Rheology Modifiers, 4 API Stability Enhancers, 4 Taste Masking, 2 Coloring Agents, 2 Chewable & Orodispersible Aids, 2 Surfactant & Foaming Agents, 1 Vegetarian Capsules, 1 Dry Powder Inhalation

22 Coating Systems & Additives
21 Fillers, Diluents & Binders
16 Thickeners and Stabilizers
14 Disintegrants & Superdisintegrants
13 Parenteral
13 Lubricants & Glidants
12 Solubilizers
12 Controlled & Modified Release
10 Direct Compression
9 Topical
8 Film Formers & Plasticizers
7 Granulation
7 Emulsifying Agents
6 Co-Processed Excipients
5 Rheology Modifiers
4 API Stability Enhancers
4 Taste Masking
2 Coloring Agents
2 Chewable & Orodispersible Aids
2 Surfactant & Foaming Agents
1 Vegetarian Capsules
1 Dry Powder Inhalation

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 36 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
36 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 36 Finished Drug Prices, 10 Annual Reports

1 US Medicaid Prescriptions
36 Finished Drug Prices
10 Annual Reports

MARKET PLACE

17 APIs, 7 FDF Dossiers

17 APIs
7 FDF Dossiers

PATENTS & EXCLUSIVITIES

9 US Patents, 7 US Exclusivities, 5 Health Canada Patents

9 US Patents
7 US Exclusivities
5 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 Others

2 Others

$ API Ref.Price (USD/KG) : 9,030 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

5 All

01 4Merck Canada Inc.

02 1Blank

filter Patent Reset all filters

5 All

01 32179396

02 12305803

03 12443089

filter Product Reset all filters

5 All

01 2POSACONAZOLE

02 3Posaconazole

filter Dosage Reset all filters

5 All

01 1SOLUTION

02 3Suspension

03 1TABLET

filter Exp Date Reset all filters

5 All

01 32014-12-20

02 12018-10-05

03 12022-04-01

Product Main Page

01

Merck Canada Inc.

Posaconazole

PharmScience R&D

Not Confirmed

Merck Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-10-05

Date Granted : 2009-12-22

Posaconazole

Brand Name : POSANOL

Patent Number : 2305803

Filing Date : 1998-10-05

Strength per Unit : 40mg / ml

Dosage Form : Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-10-05

Date Granted : 2009-12-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Merck Canada Inc.

Posaconazole

PharmScience R&D

Not Confirmed

Merck Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-12-20

Date Granted : 2001-04-17

Posaconazole

Brand Name : POSANOL

Patent Number : 2179396

Filing Date : 1994-12-20

Strength per Unit : 40mg / ml

Dosage Form : Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-12-20

Date Granted : 2001-04-17

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Merck Canada Inc.

Posaconazole

PharmScience R&D

Not Confirmed

Merck Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-04-01

Date Granted : 2011-11-01

Posaconazole

Brand Name : POSANOL

Patent Number : 2443089

Filing Date : 2002-04-01

Strength per Unit : 40mg / ml

Dosage Form : Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2022-04-01

Date Granted : 2011-11-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Merck Canada Inc.

Posaconazole

PharmScience R&D

Not Confirmed

Merck Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-12-20

Date Granted : 2001-04-17

Posaconazole

Brand Name : POSANOL

Patent Number : 2179396

Filing Date : 1994-12-20

Strength per Unit : 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2014-12-20

Date Granted : 2001-04-17

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Posaconazole

PharmScience R&D

Not Confirmed

Country

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-12-20

Date Granted : 2001-04-17

Posaconazole

Brand Name : POSANOL

Patent Number : 2179396

Filing Date : 1994-12-20

Strength per Unit : 300 mg / vial (18 mg / mL)

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2014-12-20

Date Granted : 2001-04-17

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!